Compare MYNZ & AIXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYNZ | AIXC |
|---|---|---|
| Founded | 2021 | 1996 |
| Country | Germany | United States |
| Employees | N/A | 4 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 6.4M |
| IPO Year | 2021 | N/A |
| Metric | MYNZ | AIXC |
|---|---|---|
| Price | $0.85 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 239.7K | 66.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.55 | $0.92 |
| 52 Week High | $5.34 | $2.98 |
| Indicator | MYNZ | AIXC |
|---|---|---|
| Relative Strength Index (RSI) | 48.07 | 41.30 |
| Support Level | $0.57 | $0.92 |
| Resistance Level | $0.94 | $1.42 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 69.44 | 61.11 |
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
AIxCrypto Holdings Inc is a Web3-driven decentralized artificial intelligence technology platform.